Role of Lp-PLA2 Selective Inhibitor (Darapladib) in Lowering Lipid Profile, Blood Glucose and Aortic Tissue Inflammation at Type 2 Diabetes Mellitus Rat Model
Publication Name : EUROPEAN HEART JOURNAL SUPPLEMENTS 21 (F), F58-F58, 2019
Citation :
Date : 2019